Simulations Plus, Inc.

Simulations Plus, Inc. is a global leader and premier provider in the biopharma sector, incorporated in California on July 17, 1996. The Company offers advanced software and consulting services that enhance drug discovery and development, clinical trial operations, and commercialization. Simulations Plus supports clients across the drug development lifecycle, from early discovery through all phases of clinical research and development (R&D), including clinical operations, to product commercialization. The Company serves clients as a strategic partner, offering solutions that integrate scientific software platforms, artificial intelligence-augmented insights, and expert consulting. Simulations Plus's model-informed drug development (MIDD) software and services solutions allow clients to use modeling and simulation to accelerate the drug development timeline, minimize animal testing, reduce R&D costs, comply with regulatory guidance and best practices, and increase confidence in drug safety and efficacy. The Company's clinical operations solutions support the success of clinical trials by enhancing participant diversity and retention, and driving competency and compliance with trial protocols. Additionally, its commercialization solutions provide support in obtaining regulatory approval and post-regulatory commercialization of new treatments. The Company's mission is to create value for clients by accelerating and reducing R&D costs through innovative science-based software and consulting solutions.